Stock Scorecard



Stock Summary for Staar Surgical Company (STAA) - $25.17 as of 4/10/2026 5:22:18 PM EST

Total Score

8 out of 30

Safety Score

23 out of 100

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for STAA

Positive Quarterly and Annual earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the Annual earnings growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for STAA

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for STAA

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for STAA

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for STAA (23 out of 100)

Stock Price Rating (Max of 10) 7
Historical Stock Price Rating (Max of 10) 8
Stock Price Trend (Max of 10) 2
Book Value (Max of 10) 4
Book Value to Price (Max of 10) 0
Analyst Buy Ratings (Max of 5) 2
Analyst Strong Buy Ratings (Max of 5) 0
Dividend Yield Percentage (Max of 10) 0
Operating Margin (Max of 10) 0
Trading Volume (Max of 10) 10
Price to Earnings (Max of 10) 0
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) -10

Latest News for for STAA

STAAR Surgical (STAA) Is Up 15.8% After Q1 Revenue More Than Doubles - Has The Bull Case Changed? 4/15/2026 10:10:00 PM
STAAR Surgical (STAA) Is Up 15.8% After Q1 Revenue More Than Doubles - Has The Bull Case Changed? 4/15/2026 3:40:00 AM
Staar Surgical Co (STAA) Shares Fall 9.1% -- What GF Score of 78 Tells Investors 4/15/2026 12:40:00 AM
FDA Expands Age Indication for STAAR Surgical’s EVO ICL 4/13/2026 4:09:00 PM
Is It Time To Reassess STAAR Surgical (STAA) After The Alcon Agreement Update 4/10/2026 9:09:00 PM
Is It Time To Reassess STAAR Surgical (STAA) After The Alcon Agreement Update 4/10/2026 8:40:00 AM
STAAR Surgical surges as Canaccord Genuity raises to buy on Q1 sales 4/10/2026 1:39:00 AM
STAAR Surgical (Nasdaq:STAA) - Stock Analysis 4/9/2026 8:09:00 PM
STAAR Surgical soars after company reported preliminary sales that crushed expectations 4/9/2026 10:10:00 AM
STAAR Surgical Issues Preliminary First Quarter Net Sales for 2026 4/9/2026 4:10:00 AM

Financial Details for STAA

Company Overview

Ticker STAA
Company Name Staar Surgical Company
Country N/A
Description STAAR Surgical Company designs, develops, manufactures, markets and sells implantable eye lenses and supplemental delivery systems for placing the lenses in the eye. The company is headquartered in Lake Forest, California.
Sector Name HEALTHCARE
Industry Name MEDICAL INSTRUMENTS & SUPPLIES
Most Recent Quarter 12/31/2025
Next Earnings Date 5/6/2026

Stock Price History

Last Day Price 25.17
Price 4 Years Ago 48.54
Last Day Price Updated 4/10/2026 5:22:18 PM EST
Last Day Volume 5,575,159
Average Daily Volume 1,396,056
52-Week High 30.81
52-Week Low 15.59
Last Price to 52 Week Low 61.45%

Valuation Measures

Trailing PE N/A
Industry PE 44.08
Sector PE 33.83
5-Year Average PE -0.71
Free Cash Flow Ratio 8.15
Industry Free Cash Flow Ratio 29.41
Sector Free Cash Flow Ratio 25.19
Current Ratio Most Recent Quarter 4.55
Total Cash Per Share 3.09
Book Value Per Share Most Recent Quarter 6.97
Price to Book Ratio 3.56
Industry Price to Book Ratio 2.67
Sector Price to Book Ratio 25.25
Price to Sales Ratio Twelve Trailing Months 5.11
Industry Price to Sales Ratio Twelve Trailing Months 4.87
Sector Price to Sales Ratio Twelve Trailing Months 4.40
Analyst Buy Ratings 1
Analyst Strong Buy Ratings 0

Share Statistics

Total Shares Outstanding 49,512,700
Market Capitalization 1,246,234,659
Institutional Ownership N/A

Dividends

Ex-Dividend Date N/A
Previous Dividend Amount 0.0000
Current Dividend Amount 0.0000
Total Years Dividend Increasing N/A
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 1.88%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY -10.50%
Annual Earnings Growth -298.10%
Reported EPS 12 Trailing Months -1.62
Reported EPS Past Year 0.00
Reported EPS Prior Year -0.96
Net Income Twelve Trailing Months -80,448,000
Net Income Past Year -80,448,000
Net Income Prior Year -20,208,000
Quarterly Revenue Growth YOY 18.10%
5-Year Revenue Growth 7.93%
Operating Margin Twelve Trailing Months -18.90%

Balance Sheet

Total Cash Most Recent Quarter 153,150,000
Total Cash Past Year 153,150,000
Total Cash Prior Year 144,159,000
Net Cash Position Most Recent Quarter 151,868,000
Net Cash Position Past Year 151,771,000
Long Term Debt Past Year 1,379,000
Long Term Debt Prior Year 1,379,000
Total Debt Most Recent Quarter 1,282,000
Equity to Debt Ratio Past Year 1.00
Equity to Debt Ratio Most Recent Quarter 1.00
Total Stockholder Equity Past Year 344,184,000
Total Stockholder Equity Prior Year 397,335,000
Total Stockholder Equity Most Recent Quarter 344,184,000

Free Cash Flow

Free Cash Flow Twelve Trailing Months -36,139,914
Free Cash Flow Per Share Twelve Trailing Months -0.73
Free Cash Flow Past Year -40,050,000
Free Cash Flow Prior Year -7,669,000

Options

Put/Call Ratio 0.12
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD 0.88
MACD Signal 0.28
20-Day Bollinger Lower Band 14.67
20-Day Bollinger Middle Band 20.94
20-Day Bollinger Upper Band 27.21
Beta 1.04
RSI 76.78
50-Day SMA 21.92
150-Day SMA 30.94
200-Day SMA 40.70

System

Modified 4/18/2026 8:17:18 AM EST